Why Is Everyone Talking About Gilead Sciences?
If you watched ABC's Good Morning America TV program on Tuesday, you might have seen and heard a report about a drug developed by Gilead Sciences (NASDAQ: GILD). The Wall Street Journal recently published a story about the same drug. A World Health Organization (WHO) official specifically mentioned the drug in a briefing in late February.
Why is everyone talking about Gilead and its experimental drug remdesivir? Because it just might present one of the best options for treating coronavirus disease COVID-19.
Image source: Getty Images.
Source Fool.com
